Phase I Study of EOS789

Trial Profile

Phase I Study of EOS789

Phase of Trial: Phase I

Latest Information Update: 15 Dec 2017

At a glance

  • Drugs EOS 789 (Primary)
  • Indications Hyperphosphataemia
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Chugai Pharmaceutical
  • Most Recent Events

    • 30 Jun 2016 Status changed from recruiting to discontinued.
    • 08 Jun 2016 New trial record
    • 24 Sep 2015 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top